Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

Acro Biomedical Co., Ltd.

HISTORY TOOLS
CIK: 1622996 Ticker: ACBM
Document And Entity Information - shares
9 Months Ended
Jun. 30, 2018
Aug. 13, 2018
Document And Entity Information [Abstract]  
Entity Registrant NameACRO BIOMEDICAL CO., LTD. 
Entity Central Index Key0001622996 
Trading Symbolacbm 
Current Fiscal Year End Date--09-30 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 47,660,000
Document Type10-Q 
Document Period End DateJun. 30, 2018 
Amendment Flagfalse 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusQ3 

View differences made from one quarter to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue